ORCID
- J Robert Sneyd: 0000-0003-3546-9856
Abstract
In a high-level sporting fixture, the introduction of a skilled player from the reserve bench can be a game changer. The introduction of propofol into clinical anaesthesia practice was a pharmacological game changer [1]. The drug rapidly assumed dominance over other intravenous options for induction of anaesthesia in children. Propofol use for maintenance does not yet rival that of the inhalational agent, sevoflurane, but acceptance is increasing [2] even in areas such as neonatal anaesthesia and intensive care sedation. None of the other hypnotic drugs available or investigated have competed with propofol in adults or children [3], although remimazolam is a recent competitor.
DOI Link
Publication Date
2025-01-01
Publication Title
Anaesthesia
Volume
80
Issue
3
ISSN
0003-2409
Acceptance Date
2024-11-13
Deposit Date
2024-12-09
Embargo Period
2025-12-02
Keywords
children, developmental pharmacokinetics, pharmacometrics, propofol, remimazolam
First Page
243
Last Page
247
Recommended Citation
Anderson, B., & Sneyd, J. (2025) 'Get remimazolam off the bench and into the game', Anaesthesia, 80(3), pp. 243-247. Available at: 10.1111/anae.16506
